InsiderTrades

Form 4 for FLGT Fulgent Genetics, Inc.

Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001209191-22-014778 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2022-03-02 2022-03-01 FLGT Xie Jian COO S - Sale $63.30 -622 337.6K -0.2% -$39.4K
M 2022-03-02 2022-02-28 FLGT Xie Jian COO A - Grant $0.00 +41.0K 306.2K +15% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-01 S D 622 $63.30 337,612 D — — (F3) The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019. (F4) The shares were sold in multiple transactions at prices ranging from $62.3100 to $64.3650, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
2 Common Common Stock 2022-02-28 A A 32,000 $0.00 338,234 D — — (F2) Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after March 1, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.
3 Common Common Stock 2022-02-28 A A 9,000 $0.00 306,234 D — — (F1) Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2022, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.